These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 830276)

  • 1. Transfer factor in treating hepatitis B (cont.).
    Sano M; Takeuchi T; Adachi M; Tamai Y; Ito K
    N Engl J Med; 1977 Jan; 296(1):53-4. PubMed ID: 830276
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Transfer factor in treating hepatitis B (cont.).
    Shulman ST; Hutto JH; Ayoub EM; McGuigan JE
    N Engl J Med; 1976 Oct; 295(16):898. PubMed ID: 785261
    [No Abstract]   [Full Text] [Related]  

  • 3. Transfer factor and hepatitis B: a double blind study.
    Ellis-Pegler R; Sutherland DC; Douglas R; Woodfield DG; Wilson JD
    Clin Exp Immunol; 1979 May; 36(2):221-6. PubMed ID: 477025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Active chronic hepatitis caused by the B virus (ACH-B). Analysis of a series of cases].
    Romeo F; Russo A; Liuzzo P
    Recenti Prog Med; 1980 Dec; 69(6):644-69. PubMed ID: 6166033
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of chronic B virus hepatitis with specific transfer factor.
    Mazzella G; Ronchi M; Villanova N; Mohamed AA; Pizza G; De Vinci C; Viza D; Roda E; Barbara L
    J Exp Pathol; 1987; 3(4):421-3. PubMed ID: 3454802
    [No Abstract]   [Full Text] [Related]  

  • 6. Failure of transfer-factor therapy in chronic active type B hepatitis.
    Tong MJ; Nystrom JS; Redeker AG; Marshall GJ
    N Engl J Med; 1976 Jul; 295(4):209-11. PubMed ID: 1083941
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of chronic hepatitis B].
    Carreño V; Montaño L; Torres M
    Rev Clin Esp; 1983 Oct; 171(1):73-6. PubMed ID: 6197728
    [No Abstract]   [Full Text] [Related]  

  • 8. [Active chronic hepatitis caused by the B virus (ACH-B). Recent pathogenetic acquisitions and elements of serological, clinical and histopathological diagnosis].
    Romeo F; Spina A; Cannaò G
    Recenti Prog Med; 1980 Dec; 69(6):577-643. PubMed ID: 6166032
    [No Abstract]   [Full Text] [Related]  

  • 9. New treatments for hepatitis B and C [antigen-specific transfer for A, B & C (chisolm biologicals) and thymate].
    Konlee M
    Posit Health News; 1998; (No 17):19-21. PubMed ID: 11366548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: Failure of transfer-factor therapy in chronic active type B hepatitis.
    Jain S; Thomas H; Sherlock S
    N Engl J Med; 1976 Aug; 295(9):504. PubMed ID: 940585
    [No Abstract]   [Full Text] [Related]  

  • 11. Transfer factor therapy: clinical experience and the role of the E rosette assay.
    Sutherland DC; Wilson JD; Douglas R
    N Z Med J; 1977 Jan; 85(579):3-6. PubMed ID: 319390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind evaluation of transfer factor therapy of HBsAg-positive chronic aggressive hepatitis: preliminary report of efficacy.
    Shulman ST; Hutto JH; Ayoub EM; Howlett SA; Scott B; McGuigan JE
    Cell Immunol; 1979 Mar; 43(2):352-61. PubMed ID: 476834
    [No Abstract]   [Full Text] [Related]  

  • 13. [Transfer factor therapy of viral hepatitis--report of 22 cases].
    Jin A; Ke XY; Li BQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Dec; 5(6):396-7. PubMed ID: 6233027
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfer factor in the attempted treatment of patients with HBsAg-positive chronic liver disease.
    Jain S; Thomas HC; Sherlock S
    Clin Exp Immunol; 1977 Oct; 30(1):10-5. PubMed ID: 606432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings: The effect of lymphocytic transfer factor on hepatitis B surface antigen-positive chronic liver disease.
    Jain S; Thomas HC; Sherlock S
    Gut; 1975 Oct; 16(10):836. PubMed ID: 1205315
    [No Abstract]   [Full Text] [Related]  

  • 16. Transient increase of HBsAg levels following human IFN alpha treatment signalises the patient's response in chronic active hepatitis B.
    Stancek D; Hajnická V; Blaskovicová H; Sudová J; Laktis K; Janota S; Jezek P
    Acta Virol; 1990 Sep; 34(5):457-66. PubMed ID: 1981456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer factor for the treatment of chronic active hepatitis.
    Pizza G; Viza D; Roda A; Aldini R; Roda E; Barbara L
    N Engl J Med; 1979 Jun; 300(23):1332. PubMed ID: 440338
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of multiple sclerosis using transfer factor].
    Nejtek P; St'ovícek J
    Cesk Neurol Neurochir; 1986 Nov; 49(6):419-20. PubMed ID: 3802255
    [No Abstract]   [Full Text] [Related]  

  • 19. Passive transfer of immunity in lepromatous leprosy patients by Lawrence's transfer factor.
    Mittal MM; Saha K; Maheswari HB
    J Indian Med Assoc; 1976 May; 66(9):197-9. PubMed ID: 965758
    [No Abstract]   [Full Text] [Related]  

  • 20. Amyotrophic lateral sclerosis: failure of transfer factor therapy.
    Jonas S; Wichter M; Spitler L
    Ann Neurol; 1979 Jul; 6(1):84. PubMed ID: 507764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.